Results 201 to 210 of about 1,586,237 (267)

Combined In Vitro and Computational Investigations on Synthesized Sulfonamide-Based Antidiabetic Agents. [PDF]

Pharmaceuticals (Basel)
Iacob AD, Cioancă O, Aprodu I, Tatia R, Iacob AT, Mircea C, Tutunaru D, Pavel AB, Lungu II, Dragostin OM.   +9 more
europepmc   +1 more source

Sarcopenia and chronic pain: Identification of shared genetic determinants and therapeutic implication. [PDF]

Medicine (Baltimore)
Li J, Huang J, Han J.
europepmc   +1 more source

Design and evolution of the tetracycline repressor into sulfonylurea herbicide-responsive gene switches for field crops. [PDF]

Nat Commun
McBride KE, Kakani NK, Bozhanova NG, Fang J, Lowe K, Leija C, McGonigle B, Schreiter ER, Hermanson F, Chan M, Arling M, Wang N, Cho HJ, Richey C, Hoerster G, Marvin JS, Lenderts B, McReynolds MR, Hastings C, Madrigal A, Falco SC, Lassner MW, Anand A, Gordon-Kamm W, Looger LL.   +24 more
europepmc   +1 more source

Blood Pressure Status Modulates the Therapeutic Response to Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial. [PDF]

J Diabetes
Ishibashi R, Koshizaka M, Takatsuna Y, Tatsumi T, Baba T, Yamamoto S, Yokote K.   +6 more
europepmc   +1 more source

Recent Advances in Glimepiride Solubility Improvement: A Focus on Formulation Technologies - A Narrative Review. [PDF]

Int J Nanomedicine
Fiftianingrum V, Sopyan I, Megantara S, Suhandi C.   +3 more
europepmc   +1 more source

Partial restoration of counterregulatory circulating glucagon by dapagliflozin and low-dose glibenclamide in men with type 1 diabetes: in vitro studies and randomised clinical crossover trial. [PDF]

EBioMedicine
Gao R, Spiliotis I, Dou H, Hill TG, Kothegala L, Miranda C, Abiakam N, Coleman RL, White S, Adler A, Rorsman P.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Effect of Sulfonylurea Compounds in Diabetic Children

New England Journal of Medicine, 1957
IT has been the experience of those who have used the sulfonylurea compounds that they are, for the most part, not effective in children with diabetes or in adults with unstable, juvenile type of diabetes. Our findings with Carbutamide** and Tolbutamide†† have been in agreement with this, and in only 19 cases have we attempted to treat such patients ...
Alexander Marble, Priscilla White, A Marble   +2 more
exaly   +3 more sources

Hyponatremia Due to Sulfonylurea Compounds

The Journal of Clinical Endocrinology & Metabolism, 1970
ABSTRACT In a 68-yr-old female with diabetes mellitus and idiopathic cerebral atrophy, therapeutic doses of chlorpropamide or tolbutamide induced a hyponatremic syndrome identical with that of inappropriate secretion of ADH (serum Na 117 mEq/1). Metabolic studies revealed that the hyponatremia was due in part to negative sodium balance.
G A, Hagen, T F, Frawley
openaire   +2 more sources

Effects of Sulfonylurea Compounds on Pneumocystis carinii

Journal of Infectious Diseases, 1986
Two sulfonylurea compounds, carbutamide and tolbutamide, were studied for efficacy against Pneumocystis carinii pneumonitis in the corticosteroid-treated rat model and compared with trimethoprim-sulfamethoxazole (TMP-SMZ). The chemical structures of these sulfonylureas are identical except that an amino group in carbutamide is replaced with a methyl ...
W T, Hughes, B L, Smith-McCain
openaire   +2 more sources